Olon Group, a leading global manufacturer of active pharmaceutical ingredients (APIs), has acquired Huvepharma Italia Srl, further solidifying its position as a key player in the industry. This acquisition adds a ninth manufacturing plant to Olon’s Italian network, bringing the company’s total reaction capacity to 3,250 cubic meters. The move underscores Olon’s commitment to growth and expansion, strengthening its presence in the global API market.